Technology | Neuro Imaging | August 11, 2015

Neuroreader Software Speeds Detection of Brain Volume Changes

Software generates automated report on 45 brain structures to aid early diagnosis of degenerative brain disease

Brainreader, Neuroreader, brain volume changes, degenerative brain diseases, early diagnosis

August 11, 2015 — Brainreader, a Danish medical device company, announced the launch of its new software product that has the potential to speed the detection of changes in a patient's brain volume. These are a key indicator in the diagnosis of degenerative brain diseases such as Alzheimer's disease, epilepsy and depression.

The software, Neuroreader, also can help identify changes in brain volume associated with concussions and other traumatic brain injuries.

In use by a growing number of radiologists and neuroradiologists in the United States and Europe, Neuroreader analyzes magnetic resonance imaging (MRI) scans of patients' brains and benchmarks them against a U.S. Food & Drug Administration (FDA)-cleared database of healthy brain tissues in a matter of minutes. The software measures 45 specific structures within the brain.

"Brain scans are typically analyzed visually by radiologists in what can be a time-consuming process, especially when changes in brain volume are slight," said Jamila Ahdidan, Ph.D., founder and chief technology officer of Brainreader. "When looking for changes as small as hundredths of a millimeter, a software-driven analysis allows for these tiny changes to be detected in minutes."

For more than 30 years, since the development of the MRI scanner, physicians have ordered MRI scans of the brain to identify traumatized, diseased or atrophied tissue.

"Radiologists rely on our human pattern recognition to identify tiny abnormalities in patients' brains," said Barton Branstetter, M.D., neuroradiologist at University of Pittsburgh Medical Center, Presbyterian. "But even the best radiologist cannot precisely determine the volume of every structure in the brain without hours of intensive manual calculations. Neuroreader gives us easy, reliable, reproducible volume measurements and takes the guesswork out of analyzing structures in our patients' brains."  

When treating a patient with signs of neurodegenerative diseases, the physician simply uploads the MR image to the Brainreader server. Neuroreader then analyzes the MRI scan and delivers a report in less than five minutes, indicating which brain structures' volume are abnormal and to what extent. The software, which has an intuitive interface, produces an easily interpreted automated report.

One of the brain structures analyzed is the hippocampus, the measurement of which is vital in determining a person's ability to maintain strong cognitive function, according to neurologist and Alzheimer's disease expert Majid Fotuhi, M.D., Ph.D., chairman, NeuroGrow Brain Fitness Center, McLean, Virginia, and Johns Hopkins Medicine, Baltimore.

"Measuring the size of the hippocampus is the single most important factor in determining a person's prognosis for having strong memory performance in the future," said Fotuhi. "That's where the Neuroreader comes in. It's a major breakthrough in establishing an accurate measurement of this part of the brain."

According to Fotuhi, the Neuroreader will help him and his colleagues diagnose patients early for degenerative brain diseases and to create treatment plans that can not only slow the loss of brain tissue, but even to build it back up.  "In the future, I believe it will become routine for patients - and their doctors - to know the volume of their hippocampus and to have it monitored regularly," he said.

According to Dale E. Bredesen, M.D., Augustus Rose Professor of Neurology at UCLA, and founding president and CEO of the Buck Institute for Research on Aging: "Recent publications have offered some of the first evidence for functional, sustained improvement in neurodegenerative conditions, and the ability to quantitate multiple brain region volumes reproducibly and longitudinally will be critical as therapeutic programs are being refined. Neuroreader is perfectly suited for this."

Neuroreader, which is sold as software-as-a-service, is available to hospitals radiology and neuroradiology departments on a pay-per-use or subscription model tailored to the healthcare organization's wishes.

For more information: www.brainreader.net

Related Content

The cartilage in this MRI scan of a knee is colorized to show greater contrast between shades of gray.

The cartilage in this MRI scan of a knee is colorized to show greater contrast between shades of gray. Image courtesy of Kundu et al. (2020) PNAS

News | Artificial Intelligence | September 22, 2020
September 22, 2020 — Researchers at the University of Pitts...
A new report, Magnetic Resonance Imaging Equipment Market Size, Share & Industry Analysis, conducted by Fortune Business Insights, states that the magnetic resonance imaging (MRI) equipment market reached $7.24 billion in 2019 and is projected to reach $11.36 billion by 2027

Image courtesy of Siemens Healthineers

Feature | Magnetic Resonance Imaging (MRI) | September 21, 2020 | By Melinda Taschetta-Millane
A new report,...
Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”. We have been virtualizing various aspects of our lives for many years, but the circumstances of this one has moved almost all of our lives into the virtual realm.

Getty Images

Feature | Radiology Education | September 18, 2020 | By Jef Williams
Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”.
Figure 1. Doppler flows in subpleural consolidation shows smoothly dilated branching arteries

Figure 1. Doppler flows in subpleural consolidation shows smoothly dilated branching arteries 

Feature | Radiology Imaging | September 17, 2020 | By Robert Bard, M.D. PC, DABR, FASLM
COVID-19 is routinely studied using...
 A cardiac MRI is effective in identifying inflammation of the heart muscle in athletes and can help determine when those who have recovered from COVID-19 can safely return to play in competitive sports, according to a new study by researchers at The Ohio State University Wexner Medical Center.

Getty Images

News | Cardiac Imaging | September 14, 2020
September 14, 2020 — A...
All intensive care unit equipment, including ventilators, pumps, and monitoring devices, as well as the point-of-care magnetic resonance image operator and bedside nurse, remained in the room. All equipment was operational during scanning.

All intensive care unit equipment, including ventilators, pumps, and monitoring devices, as well as the point-of-care magnetic resonance image operator and bedside nurse, remained in the room. All equipment was operational during scanning. Image courtesy of JAMA Neurology

News | Magnetic Resonance Imaging (MRI) | September 11, 2020
September 11, 2020 — A portable, low-field...
Six months after deployment, the no-show rate of the predictive model was 15.9%, compared with 19.3% in the preceding 12-month preintervention period — corresponding to a 17.2% improvement from the baseline no-show rate (p < 0.0001). The no-show rates of contactable and noncontactable patients in the group at high risk of appointment no-shows as predicted by the model were 17.5% and 40.3%, respectively (p < 0.0001).

Weekly outpatient MRI appointment no-show rates for 1 year before (19.3%) and 6 months after (15.9%) implementation of intervention measures in March 2019, as guided by XGBoost prediction model. Squares denote data points. Courtesy of the  American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Artificial Intelligence | September 10, 2020
September 10, 2020 — According to ARRS’
Vantage Galan with Advanced intelligent Clear-IQ Engine (AiCE) provides high-quality images and fast exam times

Coronal orbit images: Left original and right with AiCE.

News | Magnetic Resonance Imaging (MRI) | September 09, 2020
September 9, 2020
The global pediatric imaging market size is expected to reach $12.2 billion by 2027, registering a CAGR of 7.6% over the forecast period, according to a new report by Grand View Research, Inc.

Getty Images

News | Pediatric Imaging | August 26, 2020
August 26, 2020 — The global ...
AI-Rad Companion Prostate MR for Biopsy Support segments prostate for targeted biopsy under MRI and ultrasound fusion imaging

Image courtesy of Clinica Universidad de Navarra, Spain

News | Artificial Intelligence | August 19, 2020
August 19, 2020 — The Food and Drug Administration (FDA) has cleared two additional...